GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dezhan Healthcare Co Ltd (SZSE:000813) » Definitions » Cyclically Adjusted PS Ratio

Dezhan Healthcare Co (SZSE:000813) Cyclically Adjusted PS Ratio : 4.84 (As of Jun. 05, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Dezhan Healthcare Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Dezhan Healthcare Co's current share price is ¥3.34. Dezhan Healthcare Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥0.69. Dezhan Healthcare Co's Cyclically Adjusted PS Ratio for today is 4.84.

The historical rank and industry rank for Dezhan Healthcare Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:000813' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.63   Med: 6.51   Max: 15.98
Current: 4.74

During the past years, Dezhan Healthcare Co's highest Cyclically Adjusted PS Ratio was 15.98. The lowest was 2.63. And the median was 6.51.

SZSE:000813's Cyclically Adjusted PS Ratio is ranked worse than
76.96% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs SZSE:000813: 4.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dezhan Healthcare Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.042. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥0.69 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dezhan Healthcare Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Dezhan Healthcare Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dezhan Healthcare Co Cyclically Adjusted PS Ratio Chart

Dezhan Healthcare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.80 4.55 4.25 4.14 4.42

Dezhan Healthcare Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 2.72 4.10 4.42 4.77

Competitive Comparison of Dezhan Healthcare Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dezhan Healthcare Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dezhan Healthcare Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dezhan Healthcare Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dezhan Healthcare Co's Cyclically Adjusted PS Ratio falls into.


;
;

Dezhan Healthcare Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Dezhan Healthcare Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.34/0.69
=4.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dezhan Healthcare Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Dezhan Healthcare Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.042/115.1156*115.1156
=0.042

Current CPI (Mar. 2025) = 115.1156.

Dezhan Healthcare Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.180 99.500 0.208
201509 0.214 100.500 0.245
201512 0.272 100.600 0.311
201603 0.235 102.200 0.265
201606 0.263 101.400 0.299
201609 0.306 102.400 0.344
201612 0.173 102.600 0.194
201703 0.156 103.200 0.174
201706 0.199 103.100 0.222
201709 0.253 104.100 0.280
201712 0.382 104.500 0.421
201803 0.351 105.300 0.384
201806 0.390 104.900 0.428
201809 0.441 106.600 0.476
201812 0.290 106.500 0.313
201903 0.217 107.700 0.232
201906 0.199 107.700 0.213
201909 0.217 109.800 0.228
201912 0.167 111.200 0.173
202003 0.212 112.300 0.217
202006 0.110 110.400 0.115
202009 0.056 111.700 0.058
202012 0.056 111.500 0.058
202103 0.095 112.662 0.097
202106 0.080 111.769 0.082
202109 0.054 112.215 0.055
202112 0.099 113.108 0.101
202203 0.086 114.335 0.087
202206 0.050 114.558 0.050
202209 0.051 115.339 0.051
202212 0.072 115.116 0.072
202303 0.058 115.116 0.058
202306 0.040 114.558 0.040
202309 0.054 115.339 0.054
202312 0.075 114.781 0.075
202403 0.047 115.227 0.047
202406 0.068 114.781 0.068
202409 0.047 115.785 0.047
202412 0.055 114.893 0.055
202503 0.042 115.116 0.042

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dezhan Healthcare Co  (SZSE:000813) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Dezhan Healthcare Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Dezhan Healthcare Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dezhan Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235 Yin Chuan Road, Xinjiang, Urumqi, CHN, 830054
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
Executives
Liu Ye Executives
Zhang Yong Director
Gao Li Supervisors
Sun Ji Lu Supervisors
Wang Xiao Ping Director

Dezhan Healthcare Co Headlines

No Headlines